Closing Thoughts on Evolving Antibody-Drug Conjugate Landscape
The expert panel concludes the program with key takeaways and closing thoughts on the evolving antibody-drug conjugate space.
Read More
Educating Community Specialists on Evolving Treatment Landscape
Experts in breast, lung, and gastric malignancies provide insights on multidisciplinary care in oncology and educating community specialists.
Read More
Future Outlook for Treating Breast and Lung Cancers
Medical oncologists discuss prospects and challenges in the breast and lung cancer treatment landscapes.
Read More
Future Directions in Gastric Cancer Treatment
Specialists in gastric cancer look to the future treatment landscape and review ongoing research in the disease space.
Read More
Treatment Considerations With TROP2-Targeted Therapy
Clinical insights on best practices for treating patients with TROP2-targeted therapy.
Read More
TROP2-Targeting Antibody-Drug Conjugates
The expert panel discusses TROP2 as a target for patients with cancer who are receiving antibody-drug conjugates.
Read More
Approved Antibody-Drug Conjugates in Breast, Lung, and GI Malignancies
A review of antibody-drug conjugates approved for treatment of patients with breast, lung, or gastrointestinal cancers.
Read More
Managing T-DXd Toxicities in Gastric Cancer
Insights on managing antibody-drug conjugate toxicities for patients with gastric cancer.
Read More
Gastric Cancer Treatment: T-DXd
A GI medical oncologist discusses the role of trastuzumab deruxtecan in the gastric cancer treatment space.
Read More
Management of ADC Toxicities in Lung Cancer
A nurse practitioner provides insights on toxicity management strategies for patients with lung cancer who are receiving antibody-drug conjugates.
Read More
Antibody-Drug Conjugates in Lung Cancer
A medical oncologist reviews the antibody-drug conjugate landscape in lung cancer.
Read More
Toxicity Management for T-DM1 and T-DXd in Breast Cancer
Specialists in breast cancer review toxicity management practices for T-DM1 and trastuzumab deruxtecan [T-DXd].
Read More
Antibody-Drug Conjugates in Breast Cancer
A breast medical oncologist provides insights on antibody-drug conjugates in the breast cancer space and discusses ongoing research.
Read More
Best Practices for Patient Education Surrounding Cancer Treatment
The expert panel has a comprehensive discussion about best practices for patient education and the barriers to effective testing.
Read More
Molecular Testing Considerations in Cancer Treatment
Medical oncologists review the complexities of molecular testing, including tissue exhaustion, and discuss management approaches.
Read More
Biomarker Testing in Gastrointestinal and Lung Cancers
Comprehensive insights on biomarker testing practices for patients with lung or gastrointestinal cancers.
Read More
Molecular Testing in Breast Cancer
A breast medical oncologist and nurse practitioner review molecular testing practices for patients with breast cancer.
Read More
Mechanisms of Action of Antibody-Drug Conjugates
The expert panel discusses the history of antibody-drug conjugates and explores their mechanisms of action.
Read More
Overview of Antibody-Drug Conjugates (ADCs)
A panel of cancer-treating specialists introduce the discussion with a broad overview of antibody-drug conjugates (ADCs).
Read More